by In2Pharma | Jan 26, 2022 | News
The Netherlands The Medicines Evaluation Board (MEB) has revised two policy documents for pharmaceutical companies on the requirements for product information: MEB 5: Package leaflet of pharmaceutical products Update sections 4, 5.1, 6, 6.2, 7, 7.1, 7.4.1 Update Annex...
by In2Pharma | Dec 17, 2018 | News
EMA EMA published an updated Annex to the European Commission guideline on ‘Excipients in the labelling and package leaflet of medicinal products for human use’. The annex contains a list of all excipients known to have a recognised action or effect that need to be...
